News

Summary Available! TB Clinical Trials Consultants Meeting

On November 17 and 18, a TB Clinical Trials Consultants Meeting was held at St. George’s, University of London. The meeting was organized by CDC, CPTR, INTERTB, NIH, and TB Alliance. The meeting was convened to catalog expert opinion on the conduct of Phase 2 and Phase 3 clinical trials in tuberculosis. Sessions included:

  • Session 1: Clinical aspects of Phase 2 studies measuring sputum mycobacterial load over time
  • Session 2: Laboratory aspects of Phase 2 studies measuring sputum mycobacterial load over time
  • Session 3: Analytical aspects of Phase 2 studies measuring sputum mycobacterial load over time
  • Session 4: Clinical aspects of Phase 3 studies
  • Session 5: Laboratory aspects of Phase 3 studies
  • Session 6: Analytical aspects / endpoints of Phase 3 studies

Click here to get the summary of the meeting with all the questions and answers.

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...